Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Germany Wound Care Management Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 256 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Definitions
2.2.1 Wound Care Management
3 Healthcare Sector Review
3.1 Healthcare Sector
3.2 Healthcare Expenditure
3.3 Healthcare Infrastructure
3.3.1 Healthcare Personnel Data
3.3.2 Healthcare Facilities Data
3.4 Healthcare Policy
4 Wound Care Management in Germany
4.1 Wound Care Management Overall Revenues (2000-2012)
4.2 Wound Care Management Overall Volume (2000-2012)
4.3 Wound Care Management Overall Company Shares (2005-2006)
5 Wound Closure Devices in Germany
5.1 Wound Closure Devices Overall Revenues (2000-2012)
5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
5.1.2 Hemostats Overall Revenues (2000-2012)
5.1.3 Tissue Sealants Overall Revenues (2000-2012)
5.2 Wound Closure Devices Overall Volume (2000-2012)
5.2.1 Skin Closure Devices Overall Volume (2000-2012)
5.2.2 Tissue Sealants Overall Volume (2000-2012)
5.2.3 Hemostats Overall Volume (2000-2012)
5.3 Wound Closure Devices Average Price (2000-2012)
5.3.1 Hemostats Average Price (2000-2012)
5.4 Wound Closure Devices Distribution Share (2005-2006)
5.5 Wound Closure Devices Company Share (2005-2006)
6 Ostomy in Germany
6.1 Ostomy Overall Revenue (2000-2012)
6.2 Ostomy Overall Volume (2000-2012)
6.3 Ostomy Average Price (2000-2012)
6.4 Ostomy Distribution Share (2005-2006)
6.5 Ostomy Company Share (2005-2006)
7 Advance Wound Management in Germany
7.1 Advanced Wound Management Overall Revenue (2000-2012)
7.2 Advanced Wound Management Overall Volume (2000-2012)
7.3 Advanced Wound Management Average Price (2000-2012)
7.4 Advanced Wound Management Distribution Share (2005-2006)
7.5 Advanced Wound Management Company Share (2005-2006)
8 Traditional Wound Management in Germany
8.1 Traditional Wound Management Overall Revenue (2000-2012)
8.2 Traditional Wound Management Overall Volume (2000-2012)
8.3 Traditional Wound Management Average Price (2000-2012)
8.4 Traditional Wound Management Distribution Share (2005-2006)
8.5 Traditional Wound Management Company Share (2005-2006)
9 Compression Therapy in Germany
9.1 Compression Therapy Overall Revenue (2000-2012)
9.2 Compression Therapy Overall Volume (2000-2012)
9.3 Compression Therapy Average Price (2000-2012)
9.4 Compression Therapy Distribution Share (2005-2006)
9.5 Compression Therapy Company Share (2005-2006)
10 The HARTMANN GROUP Company Profile
10.1 Company Overview
10.2 Business Overview
10.2.1 Incontinence Management
10.2.2 Operating Theater Management
10.2.3 Other GROUP Activities
10.2.4 Wound Management
10.2.5 Products
10.2.6 History
10.3 Value Chain Analysis
10.3.1 Manufacturing
10.3.2 Product Development
10.3.3 Sales and Marketing
10.4 SWOT Analysis
10.4.1 HARTMANN GROUP Strengths
10.4.2 HARTMANN GROUP Weaknesses
10.4.3 HARTMANN GROUP Opportunities
10.4.4 HARTMANN GROUP Threats
10.5 Financial and Operational Review
10.6 Locations And Subsidiaries
10.7 Recent Developments
10.7.1 Mar 17, 2008: Hartmann Declares 2007 Results
10.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia
10.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm
10.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results
11 Ethicon, Inc. Company Profile
11.1 Company Overview
11.2 Business Overview
11.2.1 Products
11.3 Locations And Subsidiaries
11.4 Financial Deals Landscape
11.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON
11.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON
11.4.3 ETHICON Acquires Vascular Control Systems
11.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON
12 Coloplast A/S Company Profile
12.1 Company Overview
12.2 Business Overview
12.2.1 Medical Care
12.2.2 Overview
12.2.3 Major Products and Services
12.2.4 History
12.3 Value Chain Analysis
12.3.1 Manufacturing
12.3.2 Product Development
12.3.3 Sales and Marketing
12.4 SWOT Analysis
12.4.1 Coloplast A/S Strengths
12.4.2 Coloplast A/S Weaknesses
12.4.3 Coloplast A/S Opportunities
12.4.4 Coloplast A/S Threats
12.5 Financial and Operational Review
12.5.1 Financial Statements
12.6 Financial Ratios
12.7 Share Holding Structure
12.8 Locations And Subsidiaries
12.9 Financial Deals Landscape
12.9.1 Coloplast Sells Brachytherapy Business To Core Oncology
12.9.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies
12.9.3 Granville Baird Capital Partners Advisors Acquires Coloplast’s Business Unit
12.9.4 McKesson Corporation Acquires Sterling Medical Services
12.9.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor
12.10 Recent Developments
12.10.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary
12.10.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results
12.10.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results
12.10.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results
12.10.5 May 15, 2007: Colplast Declares H1 2007 Results
12.10.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results
12.10.7 Dec 13, 2006: Coloplast Appoints New Chairman
12.10.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results
13 Smith & Nephew Plc Company Profile
13.1 Company Overview
13.2 Business Overview
13.2.1 Advanced Wound Management
13.2.2 Endoscopy
13.2.3 Reconstruction
13.2.4 Trauma and Clinical Therapies
13.2.5 Products
13.2.6 History
13.3 Value Chain Analysis
13.3.1 Manufacturing
13.3.2 Product Development
13.3.3 Sales and Marketing
13.4 SWOT Analysis
13.4.1 Smith & Nephew Plc Strengths
13.4.2 Smith & Nephew Plc Weaknesses
13.4.3 Smith & Nephew Plc Opportunities
13.4.4 Smith & Nephew Plc Threats
13.5 Financial and Operational Review
13.6 Locations And Subsidiaries
13.7 Financial Deals Landscape
13.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein
13.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services
13.7.3 Smith & Nephew Acquires Plus Orthopedics Holding
13.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement
13.7.5 Smith & Nephew Acquires BlueSky Medical Group
13.7.6 Smith & Nephew Enters Into An Agreement With Covalon
13.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories
13.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew
13.7.9 Smith & Nephew Acquires Osteobiologics
13.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement
13.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity
13.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew
13.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies
13.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft
13.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement
13.7.16 Smith & Nephew Acquires VERSAJET From HydroCision
13.7.17 Smith & Nephew Terminates Acquisition Of Biomet
13.8 Recent Developments
13.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend
13.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results
13.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation
13.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM
13.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails
13.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend
13.8.7 May 03, 2007: Smith & Nephew Appoints New CEO
13.9 Smith & Nephew Plc Pipeline Products
13.9.1 R3 Modular resurfacing Acetabular system
13.9.2 R3 Ceramic-on-ceramic Acetabular System
14 Covidien Ltd./Tyco Healthcare Company Profile
14.1 Company Overview
14.2 Business Overview
14.2.1 Imaging Solutions
14.2.2 Medical Devices
14.2.3 Medical Supplies
14.2.4 Pharmaceutical Products
14.2.5 Retail Products
14.2.6 Products
14.2.7 History
14.3 Value Chain Analysis
14.3.1 Manufacturing
14.3.2 Product Development
14.3.3 Sales and Marketing
14.4 SWOT Analysis
14.4.1 Covidien Ltd./Tyco Healthcare Strengths
14.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
14.4.3 Covidien Ltd./Tyco Healthcare Opportunities
14.4.4 Covidien Ltd./Tyco Healthcare Threats
14.5 Financial and Operational Review
14.5.1 Financial Statements
14.5.2 Financial Ratios
14.6 Locations And Subsidiaries
14.7 Financial Deals Landscape
14.7.1 Covidien Signs An Agreement With Allergan
14.7.2 Covidien Acquires Scandius Biomedical
14.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million
14.7.4 Covidien And BioSynthema Enter Into Licensing Agreement
14.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien
14.7.6 Covidien To Sell European Incontinence Business
14.7.7 Covidien To Acquire Tissue Science Laboratories
14.8 Recent Developments
14.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
14.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend
14.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
14.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
14.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend
14.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
14.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
14.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
14.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
14.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
14.9 Covidien Ltd./Tyco Healthcare Pipeline Products
14.9.1 PleuraSeal Lung Sealant System
14.9.2 Sandman Intro CPAP Device
15 Regulation System
15.1 Medical Equipment Approval Process
15.1.1 Classification of Medical Devices
15.2 Conformity Assessment Process
15.2.1 Class I devices
15.2.2 Class IIa devices
15.2.3 Class IIb devices
15.2.4 Class III devices
15.3 Post Market Surveillance
16 Pricing and Reimbursement
16.1 SHI
16.1.1 Private Health Insurance
16.1.2 Diagnosis Related Groups (DRG)
17 Distribution Structure
18 APPENDIX
18.1 Global Markets Direct Research Methodology
18.2 Coverage
18.3 Secondary Research
18.4 Primary Research
18.5 Models
18.6 Forecasts
18.7 Expert Panels
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer
1.1 List of Tables
Table 1: Healthcare Personnel by Region in Germany, 2004
Table 2: Doctors by Specialty in Germany, 2000-2004
Table 3: Hospitals by Region in Germany, 2004
Table 4: Hospital Beds by Region in Germany, 2004
Table 5: Rehabilitation Centers by Region in Germany, 2004
Table 6: Rehabilitation Center Beds by Region in Germany, 2004
Table 7: Discharges by Diagnosis in Germany, 2004
Table 8: Wound Care Management, Germany, Overall Revenues ($ mn), 2000-2012
Table 9: Wound Care Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 10: Wound Care Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 11: Wound Care Management, Germany, Category Revenues ($ mn), 2000-2012
Table 12: Wound Care Management, Germany, Category Revenues ($ mn), Historic, 2000-2007
Table 13: Wound Care Management, Germany, Category Revenues ($ mn), Forecast, 2007-2012
Table 14: Wound Care Management, Germany, Category Volume (Units), 2000-2012
Table 15: Wound Care Management, Germany, Category Volume (Units), Historic, 2000-2007
Table 16: Wound Care Management, Germany, Category Volume (Units), Forecast, 2007-2012
Table 17: Wound Care Management in Germany, Overall, Company Share by Revenue ($ mn), 2005-2006
Table 18: Wound Closur e Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 19: Wound Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 20: Wound Closure Devices, Germany, Revenue by Segment ($ mn), Historic, 2000-2007
Table 21: Wound Closure Devices, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012
Table 22: Skin Closure Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 23: Skin Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 24: Hemostats, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 25: Hemostats, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 26: Tissue Sealants, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 27: Tissue Sealants, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 28: Wound Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007
Table 29: Wound Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012
Table 30: Skin Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007
Table 31: Skin Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012
Table 32: Tissue Sealants, Germany, Overall Volume (Units), Historic, 2000-2007
Table 33: Tissue Sealants, Germany, Overall Volume (Units), Forecast, 2007-2012
Table 34: Hemostats, Germany, Overall Volume (Units), Historic, 2000-2007
Table 35: Hemostats, Germany, Overall Volume (Units), Forecast, 2007-2012
Table 36: Hemostats, Germany, Average Price ($), Historic, 2000-2007
Table 37: Hemostats, Germany, Average Price ($), Forecast, 2007-2012
Table 38: Tissue Sealants, Germany, Average Price ($), Historic, 2000-2007
Table 39: Tissue Sealants, Germany, Average Price ($), Forecast, 2007-2012
Table 40: Skin Closure Devices, Germany, Average Price ($), Historic, 2000-2007
Table 41: Skin Closure Devices, Germany, Average Price ($), Forecast, 2007-2012
Table 42: Wound Closure Devices, Germany, Distribution Share by Revenue ($ mn) , 2005-2006
Table 43: Wound Closure Devices, Germany, Company Share by Revenue ($ mn) , 2005-2006
Table 44: Ostomy, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 45: Ostomy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 46: Ostomy, Germany, Overall Volume (Units), Historic, 2000-2007
Table 47: Ostomy, Germany, Overall Volume (Units), Forecast, 2007-2012
Table 48: Ostomy, Germany, Average Price ($), Historic, 2000-2007
Table 49: Ostomy, Germany, Average Price ($), Forecast, 2007-2012
Table 50: Ostomy, Germany, Distribution Share by Revenue ($ mn) , 2005-2006
Table 51: Ostomy, Germany, Company Share by Revenue ($ mn), 2005-2006
Table 52: Advanced Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 53: Advanced Wound Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 54: Advanced Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007
Table 55: Advanced Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012
Table 56: Advanced Wound Management, Germany, Average Price ($), Historic, 2000-2007
Table 57: Advanced Wound Management, Germany, Average Price ($), Forecast, 2007-2012
Table 58: Advanced Wound Management, Germany, Distribution Share by Revenue ($ mn) , 2005-2006
Table 59: Advanced Wound Management, Germany, Company Share by Revenue ($ mn) , 2005-2006
Table 60: Traditional Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 61: Traditional Wound Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 62: Traditional Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007
Table 63: Traditional Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012
Table 64: Traditional Wound Management, Germany, Average Price ($), Historic, 2000-2007
Table 65: Traditional Wound Management, Germany, Average Price ($), Forecast, 2007-2012
Table 66: Traditional Wound Management, Germany, Distribution Share by Revenue ($ mn) , 2005-2006
Table 67: Traditional Wound Management, Germany, Company Share by Revenue ($ mn) , 2005-2006
Table 68: Compression Therapy, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Table 69: Compression Therapy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Table 70: Compression Therapy, Germany, Overall Volume (Units), Historic, 2000-2007
Table 71: Compression Therapy, Germany, Overall Volume (Units), Forecast, 2007-2012
Table 72: Compression Therapy, Germany, Average Price ($), Historic, 2000-2007
Table 73: Compression Therapy, Germany, Average Price ($), Forecast, 2007-2012
Table 74: Compression Therapy, Germany, Distribution Share by Revenue ($ mn) , 2005-2006
Table 75: Compression Therapy, Germany, Company Share by Revenue ($ mn) , 2005-2006
Table 76: HARTMANN GROUP, SWOT Analysis , 2006
Table 77: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006
Table 78: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006
Table 79: HARTMANN GROUP, Subsidiaries
Table 80: HARTMANN GROUP, Subsidiaries (Contd.)
Table 81: Ethicon, Inc., Other Locations
Table 82: Ethicon, Inc., Subsidiaries
Table 83: Coloplast A/S, SWOT Analysis , 2007
Table 84: Coloplast A/S, Financial Statements, DKK Million, 2003-2007
Table 85: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007
Table 86: Coloplast A/S, Share Holding Structure
Table 87: Coloplast A/S, Other Locations
Table 88: Coloplast A/S, Subsidiaries
Table 89: Coloplast A/S, Subsidiaries (Contd.)
Table 90: Smith & Nephew Plc, SWOT Analysis, 2006
Table 91: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006
Table 92: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006
Table 93: Smith & Nephew Plc, Other Locations
Table 94: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007
Table 95: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007
Table 96: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007
Table 97: Covidien Ltd./Tyco Healthcare, Other Locations
Table 98: Covidien Ltd./Tyco Healthcare, Subsidiaries
Table 99: Currency Conversion from USD to Local Currency at 2007 Constant Rate
1.2 List of Figures
Figure 1: Healthcare Structure in Germany, 2000 - 2006
Figure 2: Healthcare Expenditure Sources in Germany, 2003
Figure 3: Healthcare Financing Framework in Germany, 2007
Figure 4: Wound Care Management, Germany, Overall Revenues ($ mn), 2000-2012
Figure 5: Wound Care Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 6: Wound Care Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 7: Wound Care Management, Germany, Category Revenues ($ mn), 2000-2012
Figure 8: Wound Care Management, Germany, Category Revenues ($ mn), Historic, 2000-2007
Figure 9: Wound Care Management, Germany, Category Revenues ($ mn), Forecast, 2007-2012
Figure 10: Wound Care Management, Germany, Category Volume (Units), 2000-2012
Figure 11: Wound Care Management, Germany, Category Volume (Units), Historic, 2000-2007
Figure 12: Wound Care Management, Germany, Category Volume (Units), Forecast, 2007-2012
Figure 13: Wound Care Management in Germany, Overall, Company Share (%), 2006
Figure 14: Wound Closure Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 15: Wound Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 16: Wound Closure Devices, Germany, Revenue by Segment ($ mn), Historic, 2000-2007
Figure 17: Wound Closure Devices, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012
Figure 18: Skin Closure Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 19: Skin Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 20: Hemostats, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 21: Hemostats, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 22: Tissue Sealants, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 23: Tissue Sealants, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 24: Wound Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007
Figure 25: Wound Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012
Figure 26: Skin Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007
Figure 27: Skin Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012
Figure 28: Tissue Sealants, Germany, Overall Volume (Units), Historic, 2000-2007
Figure 29: Tissue Sealants, Germany, Overall Volume (Units), Forecast, 2007-2012
Figure 30: Hemostats, Germany, Overall Volume (Units), Historic, 2000-2007
Figure 31: Hemostats, Germany, Overall Volume (Units), Forecast, 2007-2012
Figure 32: Hemostats, Germany, Average Price ($), Historic, 2000-2007
Figure 33: Hemostats, Germany, Average Price ($), Forecast, 2007-2012
Figure 34: Tissue Sealants, Germany, Average Price ($), Historic, 2000-2007
Figure 35: Tissue Sealants, Germany, Average Price ($), Forecast, 2007-2012
Figure 36: Skin Closure Devices, Germany, Average Price ($), Historic, 2000-2007
Figure 37: Skin Closure Devices, Germany, Average Price ($), Forecast, 2007-2012
Figure 38: Wound Closure Devices, Germany, Distribution Share (%), 2006
Figure 39: Wound Closure Devices, Germany, Company Share (%), 2006
Figure 40: Ostomy, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 41: Ostomy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 42: Ostomy, Germany, Overall Volume (Units), Historic, 2000-2007
Figure 43: Ostomy, Germany, Overall Volume (Units), Forecast, 2007-2012
Figure 44: Ostomy, Germany, Average Price ($), Historic, 2000-2007
Figure 45: Ostomy, Germany, Average Price ($), Forecast, 2007-2012
Figure 46: Ostomy, Germany, Company Share (%), 2006
Figure 47: Advanced Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 48: Advanced Wound Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 49: Advanced Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007
Figure 50: Advanced Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012
Figure 51: Advanced Wound Management, Germany, Average Price ($), Historic, 2000-2007
Figure 52: Advanced Wound Management, Germany, Average Price ($), Forecast, 2007-2012
Figure 53: Advanced Wound Management, Germany, Distribution Share (%), 2006
Figure 54: Advanced Wound Management, Germany, Company Share (%), 2006
Figure 55: Traditional Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 56: Traditional Wound Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 57: Traditional Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007
Figure 58: Traditional Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012
Figure 59: Traditional Wound Management, Germany, Average Price ($), Historic, 2000-2007
Figure 60: Traditional Wound Management, Germany, Average Price ($), Forecast, 2007-2012
Figure 61: Traditional Wound Management, Germany, Distribution Share (%), 2006
Figure 62: Traditional Wound Management, Germany, Company Share (%), 2006
Figure 63: Compression Therapy, Germany, Overall Revenues ($ mn), Historic, 2000-2007
Figure 64: Compression Therapy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 65: Compression Therapy, Germany, Overall Volume (Units), Historic, 2000-2007
Figure 66: Compression Therapy, Germany, Overall Volume (Units), Forecast, 2007-2012
Figure 67: Compression Therapy, Germany, Average Price ($), Historic, 2000-2007
Figure 68: Compression Therapy, Germany, Average Price ($), Forecast, 2007-2012
Figure 69: Compression Therapy, Germany, Distribution Share (%), 2006
Figure 70: Compression Therapy, Germany, Company Share (%), 2006
Figure 71: HARTMANN GROUP, Value Chain Analysis
Figure 72: Coloplast A/S, Value Chain Analysis
Figure 73: Smith & Nephew Plc, Value Chain Analysis
Figure 74: Covidien Ltd./Tyco Healthcare, Value Chain Analysis
Figure 75: Flowchart for Classification of Non-invasive Devices in Germany, 2007
Figure 76: Flowchart for Classification of Invasive Devices in Germany, 2007
Figure 77: Flowchart for Classification of Invasive Devices in Germany, 2007
Figure 78: Classification of Invasive Devices in Germany, 2007
Figure 79: Classification of Invasive Devices in Germany, 2007
Figure 80: Flowchart for Classification of Active Devices in Germany, 2007
Figure 81: Flowchart for Classification of Active Devices in Germany, 2007
Figure 82: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007
Figure 83: Conformity Assessment of Class-I Medical Devices in Germany, 2007
Figure 84: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007
Figure 85: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007
Figure 86: Conformity Assessment of Class-III Medical Devices in Germany, 2007
Figure 87: Global Markets Direct Methodology

Abstract

Germany Wound Care Management Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to Germany wound care management medical equipment medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of thewound care management in Germany

Scope
  • The report provides sector information broken down into detailed categories and segments in country.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008